The results showed that VCAN-AS1 levels were markedly enhanced in BC cell lines, with the highest level in MCF7 and MDA-MB-453 cells (Figure 1(d)), while miR-106a-5p was downregulated in BC cell lines (compared with MCF-10A) and had lower levels in MCF7 and MDA-MB-453 cells (Figure 1(e)). Here, VCAN is linked to breast cancer.